Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Elanco Animal Health Incorporated
  6. Summary
    ELAN   US28414H1032

ELANCO ANIMAL HEALTH INCORPORATED

(ELAN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/14/2021 06/15/2021 06/16/2021 06/17/2021 06/18/2021 Date
33.48(c) 34.81(c) 35.98(c) 35.72(c) 34.69(c) Last
3 073 237 9 818 638 7 339 229 3 637 603 5 606 730 Volume
-0.65% +3.97% +3.36% -0.72% -2.88% Change
More quotes
Financials (USD)
Sales 2021 4 712 M - -
Net income 2021 -236 M - -
Net Debt 2021 5 418 M - -
P/E ratio 2021 -71,5x
Yield 2021 0,12%
Sales 2022 4 881 M - -
Net income 2022 250 M - -
Net Debt 2022 4 803 M - -
P/E ratio 2022 67,5x
Yield 2022 0,16%
Capitalization 16 408 M 16 408 M -
EV / Sales 2021 4,63x
EV / Sales 2022 4,35x
Nbr of Employees 10 200
Free-Float 95,8%
More Financials
Company
Elanco Animal Health Incorporated is an animal health company that develops, manufactures and markets products for companion and food animals. The Company offers its products under four primary categories, such as Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. It provides a range of parasiticide portfolios in the companion... 
Read more
Sector
Pharmaceuticals
Calendar
08/17Earnings Release
More about the company
Ratings of Elanco Animal Health Incorporated
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about ELANCO ANIMAL HEALTH INCORPORATED
06/16ALERT : Rowley Law PLLC is Investigating Proposed Acquisition of Kindred Bioscie..
PR
06/16US Stocks Drop After Some FOMC Members Signal Earlier Rate Hikes
MT
06/16CLOSE UPDATE : US Stocks Decline as Fed Projects Rate Hike Implementation in 202..
MT
06/16SECTOR UPDATE : Health Care Stocks Edging Lower at Close
MT
06/16SECTOR UPDATE : Health Care Stocks Hanging On For Narrow Wednesday Gains
MT
06/16MIDDAY REPORT : Wall Street Little Changed, Awaiting FOMC Outcome
MT
06/16ELANCO ANIMAL HEALTH INCORPORATED  : to Buy Kindred Biosciences for $440 Million..
MT
06/16Wall Street Wavers Pre-Bell Ahead of FOMC Meeting
MT
06/16ELANCO ANIMAL HEALTH INCORPORATED  : Cleveland Research Upgrades Elanco Animal H..
MT
06/16ELANCO ANIMAL HEALTH INCORPORATED  : Announces Agreement to Acquire Kindred Bios..
PU
06/16ELANCO ANIMAL HEALTH INC  : Entry into a Material Definitive Agreement, Regulati..
AQ
06/16ELANCO ANIMAL HEALTH INCORPORATED  : Agrees to Buy Kindred Biosciences for $440 ..
MT
06/16ELANCO ANIMAL HEALTH INCORPORATED  : Announces Agreement to Acquire Kindred Bios..
BU
06/15HANGZHOU HIKVISION DIGITAL TECHNOLOG : U.S. Senators want Commerce Dept to list ..
RE
06/15HANGZHOU HIKVISION DIGITAL TECHNOLOG : U.S. Senators want Commerce Dept to list ..
RE
More news
News in other languages on ELANCO ANIMAL HEALTH INCORPORATED
06/16MÄRKTE USA/Wall Street mit Fed-Signal für frühere Zinswende schwächer
06/16MÄRKTE USA/Wall Street tritt vor Fed-Entscheid auf der Stelle
06/16MÄRKTE USA/Anleger halten sich vor Fed-Entscheid zurück
06/16MÄRKTE USA/Anleger dürften sich vor Fed-Entscheid zurückhalten
06/16ELANCO  : acquisition de Kindred Biosciences
More news
Analyst Recommendations on ELANCO ANIMAL HEALTH INCORPORATED
More recommendations
Analysis
REFILE-U.S. hearing on China competition told research funding falling behind
Chart ELANCO ANIMAL HEALTH INCORPORATED
Duration : Period :
Elanco Animal Health Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ELANCO ANIMAL HEALTH INCORPORATED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 38,18 $
Last Close Price 34,69 $
Spread / Highest target 26,8%
Spread / Average Target 10,1%
Spread / Lowest Target -16,4%
EPS Revisions
Managers and Directors
NameTitle
Jeffrey N. Simmons President, Chief Executive Officer & Director
Todd S. Young CFO & EVP-Corporate Governance & Strategy
R. David Hoover Independent Chairman
Christopher Keeley Chief Information Officer & Senior Vice President
Shabbir Simjee Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ELANCO ANIMAL HEALTH INCORPORATED13.11%16 408
ZOETIS INC.12.02%88 017
DECHRA PHARMACEUTICALS PLC25.39%6 459
JINYU BIO-TECHNOLOGY CO., LTD.-16.42%3 026
WUHAN KEQIAN BIOLOGY CO.,LTD-6.68%2 797
VIRBAC SA17.02%2 785